MENU
+Compare
AMGN
Stock ticker: NASDAQ
AS OF
Oct 6, 02:28 PM (EDT)
Price
$294.40
Change
-$3.49 (-1.17%)
Capitalization
160.37B

AMGN Amgen Forecast, Technical & Fundamental Analysis

Amgen is a leader in biotechnology-based human therapeutics... Show more

Industry: #Biotechnology
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMGN with price predictions
Oct 03, 2025

Momentum Indicator for AMGN turns positive, indicating new upward trend

AMGN saw its Momentum Indicator move above the 0 level on September 30, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 71 similar instances where the indicator turned positive. In of the 71 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on September 30, 2025. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

AMGN moved above its 50-day moving average on October 01, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for AMGN crossed bearishly below the 50-day moving average on August 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMGN broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AMGN entered a downward trend on September 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.598) is normal, around the industry mean (9.704). P/E Ratio (24.317) is within average values for comparable stocks, (24.419). Projected Growth (PEG Ratio) (0.959) is also within normal values, averaging (2.018). Dividend Yield (0.032) settles around the average of (0.027) among similar stocks. P/S Ratio (4.615) is also within normal values, averaging (3.548).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMGN is expected to report earnings to fall 16.28% to $5.04 per share on November 04

Amgen AMGN Stock Earnings Reports
Q3'25
Est.
$5.04
Q2'25
Beat
by $0.76
Q1'25
Beat
by $0.61
Q4'24
Beat
by $0.27
Q3'24
Beat
by $0.47
The last earnings report on August 05 showed earnings per share of $6.02, beating the estimate of $5.26. With 273.85K shares outstanding, the current market capitalization sits at 160.37B.
A.I.Advisor
published Dividends

AMGN paid dividends on September 12, 2025

Amgen AMGN Stock Dividends
А dividend of $2.38 per share was paid with a record date of September 12, 2025, and an ex-dividend date of August 22, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BTGD46.480.98
+2.15%
STKd 100% Bitcoin & 100% Gold ETF
RETL10.340.05
+0.49%
Direxion Daily Retail Bull 3X ETF
COWZ57.820.13
+0.23%
Pacer US Cash Cows 100 ETF
QAI33.72N/A
N/A
NYLI Hedge Multi-Strategy Tracker ETF
HYXF47.32-0.02
-0.04%
iShares ESG Advanced Hi Yld Corp Bd ETF

AMGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with ABBV. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then ABBV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+0.16%
ABBV - AMGN
59%
Loosely correlated
-1.12%
PFE - AMGN
54%
Loosely correlated
+1.07%
NVS - AMGN
53%
Loosely correlated
+1.08%
MRK - AMGN
51%
Loosely correlated
-0.36%
GSK - AMGN
49%
Loosely correlated
-0.78%
More